# Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis

> **NCT01125644** · PHASE3 · UNKNOWN · sponsor: **Proaparts srl** · enrollment: 10 (estimated)

## Conditions studied

- Cryptococcosis or Aspergillosis Infections

## Interventions

- **DRUG:** SPK-843

## Key facts

- **NCT ID:** NCT01125644
- **Lead sponsor:** Proaparts srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125644, "Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01125644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*